Nathalie Chauret
Corporate Officer/Principal bei BELLUS HEALTH
Profil
Nathalie Chauret is currently working as a Director at Gladius Pharmaceuticals, Inc. and Gladius Pharmaceuticals Corp.
She is also currently serving as the Vice President-Early Phase Development at BELLUS Health, Inc. In terms of education, Ms. Chauret has a graduate degree from the University of Montréal.
Aktive Positionen von Nathalie Chauret
| Unternehmen | Position | Beginn |
|---|---|---|
| BELLUS HEALTH | Corporate Officer/Principal | 01.01.2017 |
Gladius Pharmaceuticals, Inc.
 Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Gladius Pharmaceuticals, Inc. operates as a biotechnology company. It develops novel drugs to treat multi-drug-resistant bacterial infections. The company was founded by Larry D. Sutton and is headquartered in Montréal, Quebec. | Direktor/Vorstandsmitglied | - |
Gladius Pharmaceuticals Corp.
 Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | - |
Ausbildung von Nathalie Chauret
| University of Montréal | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Gladius Pharmaceuticals, Inc.
Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Gladius Pharmaceuticals, Inc. operates as a biotechnology company. It develops novel drugs to treat multi-drug-resistant bacterial infections. The company was founded by Larry D. Sutton and is headquartered in Montréal, Quebec. | Health Technology |
Gladius Pharmaceuticals Corp.
Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE. | Health Technology |
